These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 163686)

  • 1. Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h).
    Hickie RA; Walker CM; Datta A
    Cancer Res; 1975 Mar; 35(3):601-5. PubMed ID: 163686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA; Jan SH; Datta A
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterase activity in normal and neoplastic rat mammary cells grown in monolayer culture.
    Cohen LA; Straka D; Chan PC
    Cancer Res; 1976 Jun; 36(6):2007-12. PubMed ID: 178439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Some features of cyclic adenosine monophosphate metabolism in mouse liver and hepatoma 22].
    Solntseva TI; Belousova AK
    Biokhimiia; 1977 Jul; 42(7):1331-7. PubMed ID: 20168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic 3',5'-nucleotide monophosphate phosphodiesterase activity in hepatomas of different growth rates.
    Rhoads AR; Morris HP; West WL
    Cancer Res; 1972 Dec; 32(12):2651-5. PubMed ID: 4345399
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.
    Kumar S; Becker G; Prasad KN
    Cancer Res; 1975 Jan; 35(1):82-7. PubMed ID: 234030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine 3',5'-monophosphate phosphodiesterase activity in normal, differentiating, regenerating, and neoplastic liver.
    Clark JF; Morris HP; Weber G
    Cancer Res; 1973 Feb; 33(2):356-61. PubMed ID: 4347469
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative.
    Sakai T; Okano T; Makino H; Tsudzuki T
    J Cyclic Nucleotide Res; 1976; 2(3):163-70. PubMed ID: 180065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
    Menahan LA; Kemp RG
    J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of enzymes by glucagon, glucose repression, adenosine 3',5'-monophosphate concentration during carcinogenesis and in Morris 6918A hepatoma.
    Sudilovsky O; Gunter R
    Cancer Res; 1975 Apr; 35(4):1069-74. PubMed ID: 234792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells.
    Manganiello V; Vaughan M
    J Clin Invest; 1972 Oct; 51(10):2763-7. PubMed ID: 4341439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-Nucleotide phosphodiesterase activity in rat hepatoma.
    Tsou KC; Morris HP; Lo KW; Muscato JJ
    Cancer Res; 1974 Jun; 34(6):1295-8. PubMed ID: 4363652
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: a possible role for the concept of metabolite gene regulation in mammalian cells.
    Montefiori DC; Kline EL
    J Cell Physiol; 1981 Feb; 106(2):283-91. PubMed ID: 6260821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor.
    Ho RJ; Russell TR; Asakawa T; Hucks MW
    J Cyclic Nucleotide Res; 1975; 1(2):81-8. PubMed ID: 177458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5123TC.
    Dnistrian AM; Skipski VP; Barclay M; Stock CC
    Cancer Res; 1977 Jul; 37(7 Pt 1):2182-7. PubMed ID: 193636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases in neoplastic and nonneoplastic human mammary tissues.
    Singer AL; Sherwin RP; Dunn AS; Appleman MM
    Cancer Res; 1976 Jan; 36(1):60-6. PubMed ID: 174814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP phosphodiesterase activity in three Morris hepatomas.
    Criss WE; Morris HP
    Enzyme; 1975; 20(2):65-70. PubMed ID: 165075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
    Heinrich PC; Morris HP; Weber G
    Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concentration and metabolism of cyclic AMP during the early stages of hepatoma 22a growth].
    Solntseva TI; Belousova AK
    Biull Eksp Biol Med; 1977 Oct; 84(10):472-4. PubMed ID: 199292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.